eGenesis
Brookline, US · Founded 2015 · Delaware corporation · 7 known investors
Biotech
Founders & leadership
LY
Luhan YangPresident, Secretary and Treasurer30 Under 30 2014
GM
George M. ChurchDirector
GM
Geoff MacKayChief Executive Officer
Investors · 7
Alta PartnersJackson · $1M – $12M
ARCH Venture PartnersChicago · $50K – $250M
Catalio Capital Management, LPNew York
Khosla VenturesMenlo Park · $5K – $50M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
b2venturereportedBerlin · $270K – $5.4M
Kendall Capital PartnersreportedBostonvia George M. Church · board
Reported raises · per SEC filings
Form D private placements▶$25.4MraisedFeb 2024 · 11 investors · BiotechnologyRule 506(b)
▶$25.4MraisedFeb 2024 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sarah SchlesingerDirector
- Mark PruzanskiDirector
- Brad SmithDirector
- Steven GillisDirector
- Rahul KakkarDirector
- Albert WiegmanDirector
- Julie SunderlandDirector
- Michael CurtisExecutive Officer, Director
- Jennifer BergheiserExecutive Officer
- Paul SekhriDirector
- Lucio IannoneDirector
- Kathleen FanningDirector
- Offering amount
- $28.7M
- Amount sold
- $25.4M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$125MraisedMar 2021 · 43 investors · BiotechnologyRule 506(b)
▶$125MraisedMar 2021 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul SekhriExecutive Officer, Director
- Kathleen FanningDirector
- Peter HansonExecutive Officer
- Michael CurtisExecutive Officer
- Sapna SrivastavaExecutive Officer
- Steven GillisDirector
- Julie SunderlandDirector
- Isaac CiechanoverDirector
- Albert WiegmanDirector
- Lucio IannoneDirector
- Mark PruzanskiDirector
- Sarah SchlesingerDirector
- Offering amount
- $125M
- Amount sold
- $125M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100MraisedNov 2019 · 20 investors · BiotechnologyRule 506(b)
▶$100MraisedNov 2019 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bob MoreDirector
- Paul SekhriExecutive Officer, Director
- Kenneth FanExecutive Officer
- Ariel JasieExecutive Officer
- Steven GillisDirector
- Julie SunderlandDirector
- Albert L. WiegmanDirector
- Juergen EckhardtDirector
- Lucio IannoneDirector
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$12.6MraisedMar 2017 · 12 investors · BiotechnologyRule 506(c)
▶$12.6MraisedMar 2017 · 12 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Boris NikolicDirector
- Luhan YangExecutive Officer, Director, Promoter
- Geoff MacKayExecutive Officer
- Stephen GillisDirector
- Offering amount
- $38.2M
- Amount sold
- $12.6M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06c
▶$2MraisedAug 2016 · 2 investors · BiotechnologyRule 506(b)
▶$2MraisedAug 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Luhan YangExecutive Officer, Director
- George M. ChurchDirector
- Geoff MacKayExecutive Officer
- Offering amount
- $3M
- Amount sold
- $2M
- Minimum investment
- $50K
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.